Resultado de búsqueda
Annie Luetkemeyer is a clinical professor of HIV, infectious disease, and global medicine at UCSF. She has expertise in HIV therapeutic strategies, COVID-19 treatment and prevention, and viral hepatitis.
Annie F. Luetkemeyer is an American physician and researcher who is Professor of Medicine and Infectious Diseases at the University of California, San Francisco. She specializes in infectious diseases, in particular tuberculosis, human immunodeficiency virus and viral hepatitis.
Annie Luetkemeyer is a professor of medicine at UCSF and an expert in HIV, COVID-19, and other sexually transmitted infections. She has published numerous papers on clinical trials, treatment, and prevention of various diseases and has been involved in several community-based research projects.
Annie Luetkemeyer is a professor at the School of Medicine and a member of the Benioff Center for Microbiome Medicine at UCSF. She has published numerous papers on hepatitis C, COVID-19, and other infectious diseases, and has expertise in clinical trials and digital medicine.
Annie Luetkemeyer is a professor of clinical medicine at UCSF and an expert in HIV/AIDS and TB coinfection. She directs the HIV Clinical Trials Group at SFGH and conducts investigator-initiated and industry trials for HIV and TB. She also works on novel TB diagnostics and HIV and viral hepatitis coinfection.
Annie Luetkemeyer, MD, is a professor of infectious diseases at UCSF and an expert on the treatment of viral infections. She has a background in medicine, internal medicine, and clinical research, and has treated COVID-19 patients and conducted research on therapeutics.
Annie Luetkemeyer, MD. Email: aluetkemeyer@php.ucsf.edu. CFAR Awards. Comparison of Quantiferon to Conventional Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV Positive Subjects . Mentored Scientist Award, Spring 2005. Award Mentor: Diane ...
